Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 652, Issue 1-3, Pages 55-59Publisher
ELSEVIER
DOI: 10.1016/j.ejphar.2010.11.002
Keywords
Restraint stress; Dehydroepiandrosterone sulphate; Nitric oxide; Oxidative stress
Categories
Funding
- Indian Council of Medical Research
Ask authors/readers for more resources
The involvement of nitric oxide (NO) in the effects of dehydroepiandrosterone sulphate (DHEAS) on restraint stress induced neurobehavioral and brain oxidative/nitrosative stress markers was investigated in rats. Exposure of rats to restraint stress suppressed behavioral activity in the elevated plus maze and this was associated with increases in malondialdehyde (MDA) and decrease in reduced glutathione (GSH) and brain NO metabolite (NOx) levels in brain homogenates. Pretreatment with DHEAS (5-40 mg/s.c.) reversed the stress induced changes in behavioral and oxidative stress markers and also brain NOx levels. The beneficial effect of DHEAS (40 mg/kg s.c.) was blocked by pretreatment with nitric oxide synthase inhibitor, L-NAME (50 mg/kg i.p.) while pretreatment of rats with NO-precursor L-Arginine (100 mg/kg i.p.) produced potentiation of action of sub effective dose of DHEAS (5 mg/kg s.c.). The DHEAS effects were stress specific as these behavioral and biochemical parameters were not much influenced in non-stressed rats. These observations suggest that pretreatment with DHEAS has a protective effect on restraint stress induced alteration of neurobehavioral changes and brain oxidative injury in rats and NO-dependent mechanisms may be involved in this effect. (C) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available